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Response to the letter regarding the article  
“Predictive value of admission red cell distribution 
width-platelet ratio for no-reflow phenomenon  
in acute ST segment elevation myocardial  
infarction undergoing primary  
percutaneous coronary intervention”
We deeply appreciate valuable comments of 
the author [1] on our clinical study entitled “Predic-
tive value of admission red cell distribution width-
platelet ratio for no-reflow phenomenon in acute 
ST segment elevation myocardial infarction under-
going primary percutaneous coronary interven-
tion” [2]. Although providing epicardial coronary 
vessel patency, primary percutaneous coronary 
intervention (pPCI) may not achieve restoration 
of optimal myocardial reperfusion within the myo-
cardial tissue, a failure at the microvascular level 
known as no-reflow (NR) [3]. Despite achievement 
of optimal epicardial coronary flow in the major-
ity of patients treated for ST segment elevation 
myocardial infarction (STEMI) by pPCI, myocar-
dial NR is a commonly encountered phenomenon 
occurring in 5% to 50% of those patients [3]. 
The ‘no-reflow’ phenomenon in patients with 
STEMI is associated with a worse prognosis at 
short- and long-term follow-up periods [4]. What-
ever the diagnostic method used, one should take 
into consideration the dynamic nature of NR. In-
deed, NR may persist up to 48 h after reperfusion, 
although this timeframe is somewhat hypothetical 
[4]. On the other hand, a transient slowing of myo-
cardial blood flow in the infarcted area could not 
be analyzed as easily as a fixed obstruction of the 
myocardial microvasculature.
In the previously published clinical studies, 
NR has often been defined as a Thrombolysis in 
Myocardial Infarction (TIMI) flow grade £ 2 in 
the absence of macrovascular obstruction [5–11]. 
Concordantly, NR was defined as TIMI flow grades 
0–2 (no-reflow group) and reflow was defined as 
TIMI 3 flow grade in our study [12]. However, 
microvascular perfusion may also be reduced in 
patients with TIMI flow grade 3 [13]. TIMI flow 
assessment on classical coronary angiography is 
a simple and easily obtained method, although 
it has some limitations regarding to sensitivity 
and specificity for the assessment of NR. Indeed, 
capillary blood flow is not measured directly by 
angiography, and a significant proportion of TIMI 
grade 3 flow patients actually present with NR [14]. 
Therefore, other angiographic measures that have 
been developed to assess microvascular perfu-
sion include the TIMI frame count and myocardial 
blush grade (MBG) [15]. MBG is another newly 
developed angiographic imaging technique for 
assessing myocardial microvasculature and tissue 
reflow [13]. With this method cardiologists can as-
sess the myocardial tissue opacification intensity 
with longer angiographic runs, performed until the 
venous phase of contrast passage. According to 
visual or computerized signal intensity automatic 
assessment, myocardial “blush” is graded accord-
ing to a scale with four intensity grades: 0 — no 
myocardial blush; 1 — minimal myocardial blush or 
contrast density; 2 — moderate myocardial blush or 
contrast density, but less than that obtained during 
angiography of a contralateral non-infarct-related 
coronary artery; and 3 — normal myocardial 
blush or contrast density, similar to that obtained 
during angiography of a contralateral non-infarct-
related coronary artery. However, this very low 
contrast-to-noise imaging method of myocardial 
tissue opacification has the same limitations as the 
angiographic TIMI scale [16]. More importantly, 
Van’t Hof et al. [13] demonstrated relatively high 
inter- and intra-observer variabilities of MBG in 
patients with STEMI (3% and 10%, respectively).
On the other hand, timing of angiography 
may be too early to assess myocardial reperfusion 
injuries and other complex phenomena occurring 
in the hours and days after reperfusion. Therefore, 
post-PCI TIMI flow or MBG are not necessarily 
predictive of the presence of microvascular ob-
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resonance (CMR) [16]. CMR represents the most 
sensitive and specific method of assessment for 
NR [4]. Contrast enhanced CMR can be able to 
identify the lack of myocardial reperfusion after 
STEMI. CMR also allows a complete and accurate 
assessment of left ventricular status in patients 
after STEMI. Moreover, it is able to assess both 
functional and structural abnormalities of coronary 
microvasculature through MVO study, in contrast 
to conventional angiography providing a functional 
assessment regarding myocardial blood flow. Al-
though a grade 3 MBG or TIMI flow indicate a good 
prognosis at population level, up to 60% of STEMI 
patients with optimal angiographic reperfusion in-
dices (MBG and TIMI flow = 3) show NR on CMR 
at the following 72 h on an individual basis [17].
In addition to conventional angiographic meth-
ods, coronary Doppler flow wire can be used to assess 
NR. Doppler flow measurements reveal a character-
istic pattern of both systolic retrograde flow and rapid 
deceleration of diastolic flow in vessels with NR [17].
In conclusion, although MBG is found to be 
superior to TIMI flow grade for the detection of NR, 
it has some major limitations including very low 
contrast-to-noise imaging method of myocardial 
tissue opacification and relatively high intra- and 
inter-observer variabilities. On the other hand, we 
are convinced that TIMI flow grade assessment is 
more practical and swift method for NR diagnosis 
in catheterization laboratory when considering 
critical time window for the treatment.
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